Spyre Therapeutics, Inc. (SYRE)
91.17
+0.22
(+0.24%)
USD |
NASDAQ |
Sep 16, 16:00
91.99
+0.82
(+0.90%)
After-Hours: 20:00
Spyre Therapeutics Market Cap : 8.029B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 16, 2026 | 8.029B |
| September 15, 2026 | 8.009B |
| September 14, 2026 | 7.996B |
| September 11, 2026 | 7.979B |
| September 10, 2026 | 7.812B |
| September 09, 2026 | 7.655B |
| September 08, 2026 | 7.995B |
| September 04, 2026 | 7.836B |
| September 03, 2026 | 7.684B |
| September 02, 2026 | 7.666B |
| September 01, 2026 | 7.794B |
| August 31, 2026 | 7.867B |
| August 28, 2026 | 7.957B |
| August 27, 2026 | 8.244B |
| August 26, 2026 | 8.243B |
| August 25, 2026 | 9.455B |
| August 24, 2026 | 9.392B |
| August 21, 2026 | 9.378B |
| August 20, 2026 | 9.492B |
| August 19, 2026 | 9.592B |
| August 18, 2026 | 9.495B |
| August 17, 2026 | 9.212B |
| August 14, 2026 | 9.126B |
| August 13, 2026 | 8.969B |
| August 12, 2026 | 9.167B |
| Date | Value |
|---|---|
| August 11, 2026 | 9.048B |
| August 10, 2026 | 9.276B |
| August 07, 2026 | 9.239B |
| August 06, 2026 | 9.108B |
| August 05, 2026 | 9.189B |
| August 04, 2026 | 9.241B |
| August 03, 2026 | 8.360B |
| July 31, 2026 | 7.752B |
| July 30, 2026 | 8.002B |
| July 29, 2026 | 7.716B |
| July 28, 2026 | 7.881B |
| July 27, 2026 | 7.887B |
| July 24, 2026 | 8.052B |
| July 23, 2026 | 7.883B |
| July 22, 2026 | 7.819B |
| July 21, 2026 | 8.097B |
| July 20, 2026 | 7.673B |
| July 17, 2026 | 7.902B |
| July 16, 2026 | 7.420B |
| July 15, 2026 | 8.047B |
| July 14, 2026 | 7.801B |
| July 13, 2026 | 7.390B |
| July 10, 2026 | 7.706B |
| July 09, 2026 | 7.785B |
| July 08, 2026 | 7.521B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 463.87B |
| Incyte Corp. | 25.07B |
| vTv Therapeutics, Inc. | 119.98M |
| BridgeBio Pharma, Inc. | 13.34B |
| Praxis Precision Medicines, Inc. | 8.626B |
Market Cap Related Metrics
| Price to Book Value | 8.410 |
| Price | 91.17 |
| Earnings Yield | -2.39% |